News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Sebastian Other-Gee Pohl Completed 2 Years of EACR-Boehringer Ingelheim Postdoctoral Fellowship
EACR/LinkedIn
Jul 10, 2025, 16:14

Sebastian Other-Gee Pohl Completed 2 Years of EACR-Boehringer Ingelheim Postdoctoral Fellowship

European Association for Cancer Research shared a post on LinkedIn:

“We recently caught up with Sebastian Other-Gee Pohl who has now completed two years of his EACR-Boehringer Ingelheim Postdoctoral Fellowship, funding that is awarded for a period of up to three years to support excellent postdoctoral researchers in laboratories throughout Europe.

Read more.”

More posts featuring European Association for Cancer Research.

cancer EACR-Boehringer Ingelheim Postdoctoral Fellowship European Association for Cancer Research OncoDaily Oncology Sebastian Other-Gee Pohl
Special Coverage
Voices
Aug 22, 2025, 05:17
Matthew Kurian: 3 Major Trials Are Reshaping How We Treat MIBC
Voices
Aug 22, 2025, 05:11
Olivier Elemento: Blurring the Line Between Druggable and Undruggable with AI Tools
Science
Aug 22, 2025, 05:06
Letizia Pontolillo Shares ctDNA Study in HR+/HER2– Metastatic Breast Cancer
Positive
Aug 22, 2025, 05:02
Amanda Impellizzeri: Emergency Care Access Strengthened Through New Louisiana Legislation
Positive
Aug 22, 2025, 04:59
Ammira Al-Shabeeb First Newborn Genome Screening Program in the Middle East
Voices
Aug 22, 2025, 04:56
Dario Trapani Highlights the Power of Narrative and Self-Inquiry in Oncology Practice
Positive
Aug 22, 2025, 04:41
Courtney Bugler Marks Two Years at ZERO with Milestones in Mission-Driven Transformation
Voices
Aug 22, 2025, 04:37
Christopher Steer Highlights Importance of Geriatric Assessment in Older Cancer Patients
Science
Aug 22, 2025, 04:34
Tanja Obradovic Tracks Progress of HARMONi-3 and HARMONi-7 Trials in Advanced NSCLC
Science
Aug 22, 2025, 04:29
Sourat Darabi Highlights Whole Exome vs Transcriptome Sequencing in Melanoma and Thyroid Cancers
Drugs
Aug 22, 2025, 04:27
Cemiplimab (Libtayo): A Patient Guide for 2025 to Treatment, Side Effects, Dosage, and Research
Voices
Aug 22, 2025, 04:22
UICC Highlights Cancer Care Systems That Extend Beyond Hospital Walls